Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07116135 · ClinicalTrials.gov registry record · NA

Speech Understanding and Listening Effort Benefits of Hearing Instruments

A NA study of Hearing Loss, Bilateral, sponsored by Sonova.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07116135 is a NA study of Hearing Loss, Bilateral that is actively recruiting participants, run by Sonova. The registered enrollment target is 30 participants, below the 2,335-participant average among 6 other Hearing Loss, Bilateral trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07116135, a NA study of Hearing Loss, Bilateral, is actively recruiting participants, sponsored by Sonova.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical study is to investigate the benefits of hearing instrument use in adults with hearing loss. The main questions it aims to answer are: Does hearing instrument use improve speech understanding and listening effort amount people with hearing loss? Researchers will compare varying models of hearing instruments to see how speech understanding and listening effort are impacted. Participants will be asked to wearing varying hearing instruments and participate in lab-based activities to evaluate their speech understanding, listening effort, and subjective preference.

Conditions Studied

Interventions

  • DEVICE hearing instruments

Study Locations (1)

Florida

  • University of South Florida Auditory Neurosciences & Technology Lab - Tampa

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-02-05
Est. Completion 2025-12
Phase NA

Sponsor

Sonova

29 total trials

What the Registry Record Tells You About NCT07116135

The ClinicalTrials.gov registry entry for NCT07116135 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,335-participant average among 6 other Hearing Loss, Bilateral trials with a reported enrollment target (99% lower). The listed sponsor is Sonova, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hearing Loss, Bilateral appearing as the primary indexed condition, and to 1 intervention - of which hearing instruments is the first listed.

NCT07116135 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT07116135 about?

NCT07116135 is a clinical study titled "Speech Understanding and Listening Effort Benefits of Hearing Instruments". The goal of this clinical study is to investigate the benefits of hearing instrument use in adults with hearing loss. The main questions it aims to answer are: Does hearing instrument use improve speech understanding and listening effort amount people with hearing loss? Researchers will compare var...

What is the current status of trial NCT07116135?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-02-05. Estimated completion is 2025-12.

What conditions does trial NCT07116135 study?

This clinical trial studies the following conditions: Hearing Loss, Bilateral.

What interventions are being tested in trial NCT07116135?

The interventions under investigation include: hearing instruments (DEVICE).

Who is sponsoring clinical trial NCT07116135?

This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07116135 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss, Bilateral

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.